Systematic identification of barriers to human iPSC generation

Area of Science:

• Cell Biology
• Stem Cell Biology
• Genetics

Background:

• Induced pluripotent stem cells (iPSCs) offer significant potential for regenerative medicine.
• Understanding endogenous barriers is crucial for optimizing somatic cell reprogramming efficiency.

Purpose of the Study:

• To systematically identify and characterize the endogenous barriers that limit human cellular reprogramming.
• To elucidate the molecular mechanisms and network architectures underlying these barriers.

Main Methods:

• Genome-wide RNAi screening to identify inhibitory genes.
• Computational methods for pathway and network analysis.
• Single-hit validation and mechanistic investigation of identified barriers.
• Genetic interaction studies to map pathway architectures.

Main Results:

• Identified key reprogramming barriers involving transcription, chromatin regulation, ubiquitination, dephosphorylation, vesicular transport, and cell adhesion.
• Specific ADAM proteins, particularly ADAM29, were found to inhibit reprogramming via their disintegrin domain.
• Clathrin-mediated endocytosis was shown to oppose reprogramming by upregulating TGF-β signaling.
• Pathway architectures (linear, parallel, feedforward loops) were revealed for endocytosis and ubiquitination barriers.

Conclusions:

• Provided a comprehensive, global view of barriers to human cellular reprogramming.
• Highlighted the roles of specific protein families (ADAMs) and cellular processes (endocytosis, TGF-β signaling) in limiting iPSC generation.
• Demonstrated the complex network interactions that antagonize reprogramming, offering targets for therapeutic intervention.